Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2010-01-08
2011-12-27
Balasubramanian, Venkataraman (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S132000, C514S364000, C514S231500, C514S269000, C514S252130, C514S340000, C544S111000, C544S298000, C544S359000, C546S269100
Reexamination Certificate
active
08084618
ABSTRACT:
Heterocyclic compounds derived from benzotriazine, triazines, triazoles and oxadiazoles are disclosed. The methods of synthesis and of use of such heterocyclic compounds are also provided.
REFERENCES:
patent: 4160833 (1979-07-01), Diel et al.
patent: 4309211 (1982-01-01), Serban et al.
patent: 5849738 (1998-12-01), Lee et al.
patent: 6245916 (2001-06-01), Fauchere et al.
patent: 6399773 (2002-06-01), Liu et al.
patent: 6596749 (2003-07-01), Fauchere et al.
patent: 7208493 (2007-04-01), Wrasidlo et al.
patent: 7456176 (2008-11-01), Noronha et al.
patent: 7528143 (2009-05-01), Noronha et al.
patent: 7652051 (2010-01-01), Wrasidlo et al.
patent: 7816365 (2010-10-01), Schiemann et al.
patent: 2006/0292203 (2006-12-01), Dellamary et al.
patent: 2007/0149508 (2007-06-01), Noronha et al.
patent: 2007/0161645 (2007-07-01), Noronha et al.
patent: 2007/0259876 (2007-11-01), Doukas et al.
patent: 2007/0259904 (2007-11-01), Noronha et al.
patent: WO-02/064211 (2002-08-01), None
patent: WO-2004/030635 (2004-04-01), None
patent: WO-2004/030635 (2004-04-01), None
patent: WO-2005/054246 (2005-06-01), None
patent: WO-2005/054246 (2005-06-01), None
patent: WO-2005/096784 (2005-10-01), None
patent: WO-2005/096784 (2005-10-01), None
patent: WO-2006/024034 (2006-03-01), None
patent: WO-2007/032028 (2007-03-01), None
Bennett, J. C. et al. (eds) (1996).Cecil Textbook of Medicine, Philadelphia, WB Saunders Co., 20thedition, vol. 1, pp. 1004-1010.
Fabbro, D. et al. (Feb.-Mar. 2002). “Protein Kinases as Targets for Anticancer Agents: From Inhibitors to Useful Drugs,”Pharmacology&Therapeutics93(2-3):79-98.
Mass, R. D. et al. (Mar. 2004). “The HER Receptor Family: A Rich Target for Therapeutic Development,”Int. J. Radiation Oncology Phys. 58(3):932-940.
Vippagunta, S. R. et al. (May 16, 2001). “Crystalline Solids,”Advanced Drug Delivery Reviews48(1):3-26.
West, A. R.Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358-365.
International Search Report mailed on Jan. 27, 2006, for PCT Patent Application No. PCT/US2005/030614 filed on Aug. 24, 2005, published on Mar. 2, 2006 as PCT Publication No. WO 2006/024034, 1 page.
Written Opinion mailed on Jan. 27, 2006, for PCT Patent Application No. PCT/US2005/030614 filed on Aug. 24, 2005, published on Mar. 2, 2006 as PCT Publication No. WO 2006/024034, 5 pages.
European Search Report and European Written Opinion mailed on Aug. 5, 2009, for European Patent Application No. 05792421.9 filed on Aug. 24, 2005, published on Jun. 27, 2007 as European Publication No. 1 799 656, 5 pages.
Non Final Office Action mailed on Jan. 6, 2009, for U.S. Appl. No. 11/212,064, filed Aug. 24, 2005, 26 pages.
Dneprovskaia Elena
Wrasidlo Wolfgang
Balasubramanian Venkataraman
Morrison & Foerster / LLP
TargeGen, Inc.
LandOfFree
Heterocyclic compounds and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic compounds and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4306772